These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
630 related articles for article (PubMed ID: 16000453)
1. Countrywide spread of community- and hospital-acquired extended-spectrum beta-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon. Moubareck C; Daoud Z; Hakimé NI; Hamzé M; Mangeney N; Matta H; Mokhbat JE; Rohban R; Sarkis DK; Doucet-Populaire F J Clin Microbiol; 2005 Jul; 43(7):3309-13. PubMed ID: 16000453 [TBL] [Abstract][Full Text] [Related]
2. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK. Munday CJ; Whitehead GM; Todd NJ; Campbell M; Hawkey PM J Antimicrob Chemother; 2004 Sep; 54(3):628-33. PubMed ID: 15294889 [TBL] [Abstract][Full Text] [Related]
3. [Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria]. Bayraktar B; Toksoy B; Bulut E Mikrobiyol Bul; 2010 Apr; 44(2):187-96. PubMed ID: 20549952 [TBL] [Abstract][Full Text] [Related]
4. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates]. Xiong Z; Zhu D; Zhang Y; Wang F Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline. Morosini MI; García-Castillo M; Coque TM; Valverde A; Novais A; Loza E; Baquero F; Cantón R Antimicrob Agents Chemother; 2006 Aug; 50(8):2695-9. PubMed ID: 16870760 [TBL] [Abstract][Full Text] [Related]
6. Rate of transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae without contact isolation. Tschudin-Sutter S; Frei R; Dangel M; Stranden A; Widmer AF Clin Infect Dis; 2012 Dec; 55(11):1505-11. PubMed ID: 22955436 [TBL] [Abstract][Full Text] [Related]
7. Characterization of plasmid-mediated β-lactamases in fecal colonizing patients in the hospital and community setting in Spain. Garrido A; Seral C; Gude MJ; Casado C; González-Domínguez M; Sáenz Y; Castillo FJ Microb Drug Resist; 2014 Aug; 20(4):301-4. PubMed ID: 24328895 [TBL] [Abstract][Full Text] [Related]
8. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines. Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398 [TBL] [Abstract][Full Text] [Related]
9. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis. Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216 [TBL] [Abstract][Full Text] [Related]
10. [Recent evolution and characterization of extended-spectrum beta-lactamase producing enterobacteria in the CHU of Nice (2005-2007)]. Giraud-Morin C; Fosse T Pathol Biol (Paris); 2008; 56(7-8):417-23. PubMed ID: 18848404 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Cantón R; Novais A; Valverde A; Machado E; Peixe L; Baquero F; Coque TM Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():144-53. PubMed ID: 18154538 [TBL] [Abstract][Full Text] [Related]
12. Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum beta-lactamases in Enterobacteriaceae clinical isolates in Korea. Kim J; Lim YM; Jeong YS; Seol SY Antimicrob Agents Chemother; 2005 Apr; 49(4):1572-5. PubMed ID: 15793142 [TBL] [Abstract][Full Text] [Related]
13. Dissemination of IncFII(K)-type plasmids in multiresistant CTX-M-15-producing Enterobacteriaceae isolates from children in hospital paediatric oncology wards. Dolejska M; Brhelova E; Dobiasova H; Krivdova J; Jurankova J; Sevcikova A; Dubska L; Literak I; Cizek A; Vavrina M; Kutnikova L; Sterba J Int J Antimicrob Agents; 2012 Dec; 40(6):510-5. PubMed ID: 23043911 [TBL] [Abstract][Full Text] [Related]
14. Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital. Gibold L; Robin F; Tan RN; Delmas J; Bonnet R Clin Microbiol Infect; 2014 Jan; 20(1):O20-6. PubMed ID: 23927626 [TBL] [Abstract][Full Text] [Related]
15. Surveillance of extended-spectrum beta-lactamases from clinical samples and faecal carriers in Barcelona, Spain. Miró E; Mirelis B; Navarro F; Rivera A; Mesa RJ; Roig MC; Gómez L; Coll P J Antimicrob Chemother; 2005 Dec; 56(6):1152-5. PubMed ID: 16244084 [TBL] [Abstract][Full Text] [Related]
16. Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal. Mendonça N; Leitão J; Manageiro V; Ferreira E; Caniça M Antimicrob Agents Chemother; 2007 Jun; 51(6):1946-55. PubMed ID: 17371815 [TBL] [Abstract][Full Text] [Related]
17. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Ko KS; Lee MY; Song JH; Lee H; Jung DS; Jung SI; Kim SW; Chang HH; Yeom JS; Kim YS; Ki HK; Chung DR; Kwon KT; Peck KR; Lee NY Diagn Microbiol Infect Dis; 2008 Aug; 61(4):453-9. PubMed ID: 18482815 [TBL] [Abstract][Full Text] [Related]